Literature DB >> 15467532

Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis.

Francesmary Modugno1, Roberta B Ness, Glenn O Allen, Joellen M Schildkraut, Faith G Davis, Marc T Goodman.   

Abstract

OBJECTIVE: Women with endometriosis may be at an increased risk of ovarian cancer. It is not known whether reproductive factors that reduce the risk of ovarian cancer in general also reduce risk in women with endometriosis. We investigated whether the odds ratios for ovarian cancer that were associated with oral contraceptive use, childbearing, hysterectomy, and tubal ligation differ among women with and without endometriosis. STUDY
DESIGN: We pooled information on the self-reported history of endometriosis from 4 population-based case-controlled studies of incident epithelial ovarian cancer, comprising 2098 cases and 2953 control subjects. We obtained data on oral contraceptive use, childbearing, breastfeeding, gynecologic surgical procedures, and other reproductive factors on each woman. Multivariable unconditional logistic regression was used to calculate odds ratios and 95% CI for ovarian cancer among women with endometriosis compared with women without endometriosis. Similar methods were used to assess the frequencies of risk factors among women with and without endometriosis. Adjustments were made for age, parity, oral contraceptive use, tubal ligation, family history of ovarian cancer, and study site.
RESULTS: Women with endometriosis were at an increased risk of ovarian cancer (odds ratio, 1.32; 95% CI, 1.06-1.65). Using oral contraceptives, bearing children, and having a tubal ligation or hysterectomy were associated with a similar reduction in the odds ratios for ovarian cancer among women with and without endometriosis. In particular, the use of oral contraceptives for >10 years was associated with a substantial reduction in risk among women with endometriosis (odds ratio, 0.21; 95% CI, 0.08-0.58).
CONCLUSION: Women with endometriosis are at an increased risk of epithelial ovarian cancer. Long-term oral contraceptive use may provide substantial protection against the disease in this high-risk population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467532     DOI: 10.1016/j.ajog.2004.03.035

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  48 in total

1.  The parity-associated microenvironmental niche in the omental fat band is refractory to ovarian cancer metastasis.

Authors:  Courtney A Cohen; Amanda A Shea; C Lynn Heffron; Eva M Schmelz; Paul C Roberts
Journal:  Cancer Prev Res (Phila)       Date:  2013-09-10

2.  National German Guideline (S2k): Guideline for the Diagnosis and Treatment of Endometriosis: Long Version - AWMF Registry No. 015-045.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; R-L De Wilde; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-12       Impact factor: 2.915

3.  Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach.

Authors:  Seijeoung Kim; Therese A Dolecek; Faith G Davis
Journal:  Soc Sci Med       Date:  2010-04-22       Impact factor: 4.634

4.  A rare presentation of catamenial hemoptysis as a solitary pulmonary nodule.

Authors:  Kun Woo Kim; Jae-Ik Lee; Eun Young Kim; Hyunchul Kim; Seung-Ho Lee; Shin Myung Kang; Young Saing Kim; Jeong Ho Kim
Journal:  Emerg Radiol       Date:  2014-09-07

5.  Interdisciplinary S2k Guidelines for the Diagnosis and Treatment of Endometriosis: Short Version - AWMF Registry No. 015-045, August 2013.

Authors:  U Ulrich; O Buchweitz; R Greb; J Keckstein; I von Leffern; P Oppelt; S P Renner; M Sillem; W Stummvoll; K-W Schweppe
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

Review 6.  Endometriosis: a high-risk population for major chronic diseases?

Authors:  Marina Kvaskoff; Fan Mu; Kathryn L Terry; Holly R Harris; Elizabeth M Poole; Leslie Farland; Stacey A Missmer
Journal:  Hum Reprod Update       Date:  2015-03-11       Impact factor: 15.610

7.  Association between DNA damage response and repair genes and risk of invasive serous ovarian cancer.

Authors:  Joellen M Schildkraut; Edwin S Iversen; Melanie A Wilson; Merlise A Clyde; Patricia G Moorman; Rachel T Palmieri; Regina Whitaker; Rex C Bentley; Jeffrey R Marks; Andrew Berchuck
Journal:  PLoS One       Date:  2010-04-08       Impact factor: 3.240

8.  Endometriosis-associated ovarian cancer: A ten-year cohort study of women living in the Estrie Region of Quebec, Canada.

Authors:  Aziz Aris
Journal:  J Ovarian Res       Date:  2010-01-19       Impact factor: 4.234

9.  Cancers, infections, and endocrine diseases in women with endometriosis.

Authors:  Julie Anne L Gemmill; Pamela Stratton; Sean D Cleary; Mary Lou Ballweg; Ninet Sinaii
Journal:  Fertil Steril       Date:  2009-11-27       Impact factor: 7.329

10.  Differences in characteristics among 1,000 women with endometriosis based on extent of disease.

Authors:  Ninet Sinaii; Katherine Plumb; Louise Cotton; Ann Lambert; Stephen Kennedy; Krina Zondervan; Pamela Stratton
Journal:  Fertil Steril       Date:  2007-05-11       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.